CALL US: 1-352-733-0111

Leiomyosarcoma: Research Studies

1 Related Result(s)

  1. A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Doxorubicin plus Olaratumab versus Doxorubicin plus Placebo in Patients with Advanced or Metastatic Soft Tissue Sarcoma

    The primary objective is to compare doxorubicin plus olaratumab versus doxorubicin plus placebo with respect to overall survival (OS) in 2 populations: (1)...